258 related articles for article (PubMed ID: 21725368)
1. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.
Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM
Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368
[TBL] [Abstract][Full Text] [Related]
2. Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide.
Cates CC; Arias AD; Nakayama Wong LS; Lamé MW; Sidorov M; Cayanan G; Rowland DJ; Fung J; Karpel-Massler G; Siegelin MD; Greene LA; Angelastro JM
Oncotarget; 2016 Mar; 7(11):12718-30. PubMed ID: 26863637
[TBL] [Abstract][Full Text] [Related]
3. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytes.
Angelastro JM; Mason JL; Ignatova TN; Kukekov VG; Stengren GB; Goldman JE; Greene LA
J Neurosci; 2005 Apr; 25(15):3889-99. PubMed ID: 15829641
[TBL] [Abstract][Full Text] [Related]
5. Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord.
Hitoshi Y; Harris BT; Liu H; Popko B; Israel MA
Cancer Res; 2008 Oct; 68(20):8507-15. PubMed ID: 18922925
[TBL] [Abstract][Full Text] [Related]
6. Expression and targeting of transcription factor ATF5 in dog gliomas.
York D; Sproul CD; Chikere N; Dickinson PJ; Angelastro JM
Vet Comp Oncol; 2018 Mar; 16(1):102-107. PubMed ID: 28480569
[TBL] [Abstract][Full Text] [Related]
7. Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.
Angelastro JM; Canoll PD; Kuo J; Weicker M; Costa A; Bruce JN; Greene LA
Oncogene; 2006 Feb; 25(6):907-16. PubMed ID: 16170340
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.
Sheng Z; Li L; Zhu LJ; Smith TW; Demers A; Ross AH; Moser RP; Green MR
Nat Med; 2010 Jun; 16(6):671-7. PubMed ID: 20495567
[TBL] [Abstract][Full Text] [Related]
9. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
[TBL] [Abstract][Full Text] [Related]
10. SCCRO promotes glioma formation and malignant progression in mice.
Broderick SR; Golas BJ; Pham D; Towe CW; Talbot SG; Kaufman A; Bains S; Huryn LA; Yonekawa Y; Carlson D; Hambardzumyan D; Ramanathan Y; Singh B
Neoplasia; 2010 Jun; 12(6):476-84. PubMed ID: 20563250
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas.
Restrepo A; Smith CA; Agnihotri S; Shekarforoush M; Kongkham PN; Seol HJ; Northcott P; Rutka JT
Neuro Oncol; 2011 Jan; 13(1):42-50. PubMed ID: 21075782
[TBL] [Abstract][Full Text] [Related]
12. HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation.
Li G; Xu Y; Guan D; Liu Z; Liu DX
J Biol Chem; 2011 Jun; 286(23):20251-9. PubMed ID: 21521685
[TBL] [Abstract][Full Text] [Related]
13. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
Jiang Y; Boije M; Westermark B; Uhrbom L
Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus immediate-early protein promotes survival of glioma cells through interacting and acetylating ATF5.
Hu M; Wang B; Qian D; Wang M; Huang R; Wei L; Li L; Zhang L; Liu DX
Oncotarget; 2017 May; 8(19):32157-32170. PubMed ID: 28473657
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of JAM-A in gliomas.
Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of platelet-derived growth factor (PDGF) B chain and PDGF B-type receptor in human gliomas.
Mauro A; Bulfone A; Turco E; Schiffer D
Childs Nerv Syst; 1991 Dec; 7(8):432-6. PubMed ID: 1665101
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells.
Li G; Li W; Angelastro JM; Greene LA; Liu DX
Mol Cancer Res; 2009 Jun; 7(6):933-43. PubMed ID: 19531563
[TBL] [Abstract][Full Text] [Related]
18. Novel function of transcription factor ATF5: blockade of p53-dependent apoptosis induced by ionizing irradiation.
Nishioka T; Miyai Y; Haga H; Kawabata K; Shirato H; Homma A; Shibata K; Yasuda M
Cell Struct Funct; 2009; 34(1):17-22. PubMed ID: 19293535
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor ATF5: role in neurodevelopment and neural tumors.
Greene LA; Lee HY; Angelastro JM
J Neurochem; 2009 Jan; 108(1):11-22. PubMed ID: 19046351
[TBL] [Abstract][Full Text] [Related]
20. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
